The elevated production of IL-13 by Th22 cells in EOCRC patients suggests a potential shift in their functional profile, which together with their reduced levels, may promote a proinflammatory environment with an impaired capacity for tissue repair and immune regulation in EOCRC, potentially leading to unchecked tumor progression. Here, IL13 is linked to neoplasm.